Please check back as we update this page.
Alexandra Adams, MD, PhD
Dr. Alexandra Adams is Director of the Center for American Indian and Rural Health Equity (CAIRHE), an NIH COBRE Center at Montana State University dedicated to working in partnership with underserved communities to improve health. In July 2016, she relocated to Bozeman, MT from Madison, Wisconsin, where she has worked as a Professor of Family Medicine and Community Health since 1999 at the University of Wisconsin School of Medicine and Public Health. At the UW, Dr. Adams was the Director of the Collaborative Center for Health Equity, and Assistant Director for Community Engagement, UW Institute for Clinical and Translational Research, 2008–2016, and Director, UW Cancer Center’s Cancer Health Disparities Initiative, 2009–2016.
Dr. Adams has over 17 years of community based participatory research experience with American Indian communities nationally, and has received over $20 million in community-partnered research funding from NIH. Her research focuses on participatory research partnerships with underserved communities, and family and community change for early prevention of chronic disease. Her current research is in partnership with five American Indian communities nationally on the Healthy Children, Strong Families project. This NHLBI funded R01 is a randomized trial of a healthy lifestyle intervention for AI families with children ages 2-5.
Kimlin Tam Ashing, PhD
Dr. Kimlin Tam Ashing is a professor, and directs the Center of Community Alliance for Research and Education (CCARE) at City of Hope. She received her doctorate in Clinical Psychology from the University of Colorado, Boulder. As an advocate-scientist, her work is advancing community, theoretical and methodological approaches in behavioral, implementation and translational sciences. She serves on the Board of Directors for the American Psychosocial Oncology Society, National Advisory Council for the Asian Pacific Islander Native Hawaiian Cancer Survivors Network, and on the Executive Council of American Cancer Society, Los Angeles. She serves as Scientific Advisor to Latinas Contra Cancer, the African-Caribbean Cancer Consortium, and the Southern Los Angeles Patient Navigation and Wellness Center.
She is the notable leader in examining cancer inequities, survivorship and quality of life, and has published over 78 articles and book chapters. Her life work is to increase the voice and representation of underrepresented groups in cancer research. To achieve her aims she focuses on her program of research, mentoring students and trainees, and increasing the capacity of community organizations to engage in research, and address their community’s cancer and chronic conditions. Her scholarship is to understand how culture, ethnicity, socio-ecological and systemic contexts influence health and patient centered outcomes. She then applies this knowledge to design and implement interventions for community health improvements.
Dr. Ashing partners with community advocates and multi-sectoral partners to develop and implement community participatory programs and interventions to reduce the risk and burden of chronic illnesses, including cancer, obesity and diabetes. She is a community-minded researcher who is guided by a bio-psychosocial and eco-cultural paradigm. Her studies are multicultural including diverse ethnic groups, including African Americans, Afro-Caribbean Americans, Latino Americans, Chinese Americans, Japanese Americans, Filipino Americans, Korean Americans and European Americans.
As a woman of color raised in a multicultural (Chinese and Afro-Caribbean) and multilingual home, and the youngest of eight siblings, she recognized the salience of culture and context very early in her life. As the daughter of two former cancer survivors, and as a psychologist, she is compassionate and passionate about her work to reduce cancer inequities and enhance health outcomes for underserved communities.
Monica L. Baskin, PhD
Dr. Monica Baskin is a Professor in the Division of Preventive Medicine and Vice Chair for Culture and Diversity in the Department of Medicine of the UAB School of Medicine. She holds a secondary faculty appointment in the Department of Nutrition Sciences in the UAB School of Health Professions and center appointments in the UAB Comprehensive Cancer Center (CCC), UAB Minority Health and Research Center (MHRC), UAB Nutrition Obesity Research Center (NORC), UAB Center for Exercise Medicine (CEM), UAB Center for Outcomes and Effectiveness Research and Education (COERE), UAB Comprehensive Cardiovascular Center (CCVC), UAB Diabetes Research and Training Center (DRTC), and UAB Center for Cardiovascular Biology (CCB). Dr. Baskin received her Bachelor of Arts in psychology and sociology from Emory University, and a Master of Science in Community Counseling and Ph.D. in Counseling Psychology from Georgia State University. She is a licensed psychologist with research focuses on minority health and health disparities. Much of her work links academic partners to community- and faith-based networks. She has led multiple funded research projects focusing on individual, family, and environmental factors associated with healthy eating, physical activity, obesity, and cancer prevention and control. Currently, she leads multiple NIH-funded studies including: (1) a randomized trial of a multi-level weight loss program for African American women in rural Alabama and Mississippi, (2) a randomized trial of a multi-level weight loss program for cancer survivors in rural Alabama, (3) a pilot health promotion study for children enrolled in Head Start and their families, and (4) an observational study investigating the social determinants of maternal and child outcomes of overweight and obese black and white women living in Birmingham, AL. Dr. Baskin has published in the areas of obesity, culturally competent interventions, health promotion programs in black churches, and motivational interviewing (MI). She is also an invited member of the African-American Collaborative Obesity Research Network (AACORN), a national research group of investigators with social and cultural grounding in African American life experiences and obesity-related expertise.
Leslie Bernstein, PhD
Dr. Leslie Bernstein returned to UCLA in 1964, after marrying and having children, to receive her BA in Mathematics (highest honors). Years later she attended USC to earn her MS (1978) in gerontology and PhD (1981) in biometry. Subsequently, while working as a biostatistician, she realized she wanted to pursue research in cancer epidemiology.
Dr. Bernstein worked from 1978 through 2007 in the Department of Preventive Medicine at USC’s Keck School of Medicine where she was a tenured professor (1991) and held the AFLAC, Inc., Endowed Chair in Cancer Research (1997-2007). She served as the medical school’s Senior Associate Dean for Faculty Affairs (1996-2003), as USC’s Vice Provost for Medical Affairs (2003-2005) and as Scientific Director for the Los Angeles County Cancer Surveillance Program (1987-2007). In 2007, Dr. Bernstein moved her research program to City of Hope, serving as professor, Dean for Faculty Affairs (2007-2014), Director of the Division of Cancer Etiology (2007-2016) and Interim Chair of the Department of Population Sciences (2015).
Dr. Bernstein’s research focuses on breast cancer, seeking to identify modifiable lifestyle factors that reduce incidence and extend survival. She identified the link between physical activity and reduced risk of breast cancer and has pursued research investigating the long-term chronic disease outcomes of therapeutic regimens for breast cancer. For example, she showed that the increased risk of endometrial cancer associated with tamoxifen therapy is mediated by body weight and prior use of estrogen therapy. Dr. Bernstein has served as PI of the California Teachers Study (2006-2015), a prospective cohort of 133,479 female public school professionals formed in 1995 to study breast and other cancer outcomes. In addition to her ongoing research on breast cancer, she has conducted studies of risk factors for endometrial cancer, non-Hodgkin lymphoma and esophageal adenocarcinoma and gastric cardia cancer. Dr. Bernstein also participates in a number of national and international cancer research collaborations and pooling projects.
Among her many honors, Dr. Bernstein received several awards for her research including the AACR-Prevent Cancer Award, Susan G. Komen for the Cure Brinker Award, American Society for Preventive Oncology Distinguished Achievement Award, and NCI’s Rosalind E. Franklin Award. For her contributions to epidemiology as an educator, mentor, and role model, she received the American College of Epidemiology Abraham Lilienfeld Award and the Ron Ross Award at the PacRim Breast and Prostate Cancer Meeting. Dr. Bernstein received the Presidential Medallion, USC’s highest honor, and the Elaine Stevely Hoffman Award for her dedicated service to the USC Keck School of Medicine. Her portrait hangs in City of Hope’s Gallery of Outstanding Scientists. Nationally and internationally she is known for her willingness to mentor others in their pursuit of a successful academic career, sharing her expertise and insight.
Scott J. Bultman, PhD
Dr. Scott Bultman is an Associate Professor in the Department of Genetics and a member of the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. His research interest is the role of chromatin-modifying factors and epigenetics in mammalian development and disease states using mouse models. As a graduate student at the Oak Ridge National Laboratory, he cloned the agouti coat-color gene, which was arguably the first “obesity gene” to be characterized at the molecular level. As a postdoctoral fellow at Case Western Reserve University, he knocked out the BRG1 chromatin remodeler and demonstrated that it is required for embryogenesis and also functions as a tumor suppressor. He has continued this project in his own lab by creating an allelic series of Brg1 mutations to study its function in a range of tissues and physiologic processes. He has expanded his research program to include the study of interactions between diet and gut microbiota in host epigenetics and cancer susceptibility. This line of work, which is now the primary focus of his lab, is investigating butyrate, which is a short-chain fatty acid produced by bacterial fermentation of dietary fiber that functions as an energy source and a histone deacetylase (HDAC) inhibitor in the colon. This work has revealed a “metaboloepigenetic” mechanism of tumor suppression as described in a number of recent publications in high-impact journals such as Cell Metabolism, Molecular Cell, and Cancer Discovery. Most recently, his work has expanded further by utilizing a novel 3D “minigut” organ culture system as well as mouse models to investigate microbial gene products and metabolites that influence colorectal cancer regardless of whether or not the underlying mechanisms involve epigenetics.
Supported by the NIH and USDA, Dr. Bultman has published over 65 papers and has served the community in a variety of capacities. He is a member of the NIH-funded Mutant Mouse Regional Research Centers (MMRRC) consortium. He has advised The American Cancer Society (ACS), organized Abcam symposia, and served on a number of NIH study sections including Chemo/Dietary Prevention (CDP) as well as other federal agencies and foundations that support research on diet and cancer prevention such as the United States Department of Agriculture (USDA) and the American Institute for Cancer Research (AICR).
Robert S. Chapkin, PhD
Dr. Robert Chapkin is a member of the Program in Integrative Nutrition & Complex Diseases, and Deputy Director of the NIEHS Center for Translational Environmental Health Research at Texas A&M University. He received his BS in Nutrition and Biochemistry from the University of Guelph, Ontario, Canada; an MSc in Nutrition from the University of Guelph, 1983, and a PhD in Nutrition and Physiology Chemistry from the University of California-Davis in 1986. After completing a postdoctoral fellowship in Cancer Biology in the School of Medicine at the University of California-Davis in 1988, he joined the faculty at Texas A&M University. Dr. Chapkin is currently a Distinguished Professor, Regents Professor and University Faculty Fellow and during the past 28 years has published 249 peer-reviewed articles in nutrition, membrane biology, cancer biology, non-invasive biomarkers and immunology. He holds appointments in the Departments of Nutrition & Food Science, Biochemistry & Biophysics, Veterinary Integrated Biosciences, and Microbial Pathogenesis & Immunology. He was recently awarded an NCI R35 Outstanding Investigator grant to extend novel cancer prevention strategies to delineate the nuclear and plasma membrane targeted mechanisms modulating stem cell responses to exogenous (diet-derived) and endogenous (gut microbial) bioactive agents.
Steven K. Clinton, MD, PhD
Dr. Steven Clinton is currently the John B. and Jane T. McCoy Chair in Cancer Research and Professor in the Division of Medical Oncology of the Department of Internal Medicine, College of Medicine. He holds joint appointments in 6 departments among 4 colleges, including the Department of Human Nutrition, Department of Environmental Health Sciences, Division of Medical Dietetics, and Department of Food Science and Technology. Dr. Clinton is the Director of the Prostate and Genitourinary Oncology Clinical Program of The James Cancer Hospital at Ohio State integrating the efforts of faculty in medical oncology, urology, and radiation oncology. He serves The Ohio State University Comprehensive Cancer Center and Program Leader for Molecular Carcinogenesis and Chemoprevention. His campus-wide activities include serving as Associate Director of The Food Innovation Center and The Food for Health Discovery Theme. He received his Ph.D. in Nutritional Sciences and M.D. at the University of Illinois in Champaign-Urban and pursued his Internal Medicine Residency at the University of Chicago, followed by Medical Oncology Fellowship at Dana Farber Cancer Institute and Harvard Medical School where he remained on faculty for a decade prior to joining The Ohio State University. Dr. Clinton is recognized for his research in the areas of diet, nutrition, and cancer. His research team focuses primarily upon prostate cancer and their efforts include metabolic epidemiology, clinical intervention trials, as well as basic laboratory studies of cellular and molecular biology resulting in over 200 scientific publications, reviews, and book chapters. Dr. Clinton has contributed significantly to public health through serving the Institute of Medicine of the National Academy of Sciences to define Dietary Reference Intakes and most recently serving on the USDA/HHS scientific advisory committee for Dietary Guidelines for America 2015-2020.
Cindy D. Davis, PhD
Dr. Cindy Davis is the Director of Grants and Extramural Activities in the Office of Dietary Supplements (ODS). In this position, she actively engages and encourages partnerships with other NIH Institutes and Centers to facilitate funding of grants that are of high relevance to ODS mission and goals. She is also actively involved in a number of government working groups on the microbiome. Before coming to ODS, she was a Program Director in the Nutritional Sciences Research Group at the National Cancer Institute. Dr. Davis received her bachelor’s degree with honors in nutritional sciences from Cornell University in Ithaca, New York and her doctorate degree in nutrition with a minor in human cancer biology from the University of Wisconsin- Madison. She completed her postdoctoral training at the Laboratory of Experimental Carcinogenesis at the National Cancer Institute. She then joined the Grand Forks Human Nutrition Research Center, USDA, as a research nutritionist. In 2000, she received a Presidential Early Career Award for Scientists and Engineers and was named the USDA Early Career Scientist. She has published more than 125 peer-reviewed journal articles and eleven invited book chapters.
Wendy Demark-Wahnefried, PhD, RD
Dr. Wendy Demark-Wahnefried is Professor and Webb Endowed Chair of Nutrition Sciences. Dr. Demark-Wahnefried began her career as a cancer researcher at Duke University where she was on faculty for 17 years, then was recruited to MD Anderson and then came to UAB in 2010 as the Associate Director for Cancer Prevention and Control in the Cancer Center. She has led seven NIH-funded clinical trials of diet and physical activity interventions in cancer patients and survivors and has participated as a co-investigator on several other investigations. Her research in nutrition and cancer control and survivorship has produced over 200 scientific publications, and recognition as a Komen Professor of Survivorship and an American Cancer Society Clinical Research Professor. Dr. Demark-Wahnefried serves on several committees, including the American Cancer Society’s Guidelines Panel for Nutrition and Physical Activity, World Cancer Research Fund, American College of Sports Medicine Guidelines Panel for Physical Activity in Cancer Survivors, American Society of Clinical Oncology Committee on Cancer Survivorship and Energy Balance, and the National Cancer Policy Forum of the Institute of Medicine.
Suzanne Dixon, MPH, MS, RDN
Suzanne Dixon, a registered dietitian and epidemiologist, is best known as the creator of an award-winning cancer nutrition website, which was acclaimed by the New York Times and Time magazine. She has received numerous awards from the Academy of Nutrition and Dietetics, and is Past Chair of the Oncology Nutrition Dietetic Practice Group. Suzanne managed the Outpatient Oncology Nutrition Program at the University of Michigan Comprehensive Cancer Center, and has served as an appointed member to the National Comprehensive Cancer Network (NCCN). She was recently appointed to serve on the American Society of Clinical Oncology Obesity and Energy Balance Work Group, and has authored journal articles, textbook chapters, and consumer health publications. She has developed and taught medical, nursing, public health, and complementary medicine coursework. Suzanne received her training in epidemiology and nutrition at the University of Michigan, School of Public Health at Ann Arbor.
Johanna Dwyer, DSc, RD
Dr. Johanna Dwyer is Professor of Medicine (Nutrition) and Community Health at the Tufts University School of Medicine, and Adjunct Professor of Nutrition at Tufts University Friedman School of Nutrition Science and Policy. She is also Senior Scientist at the Jean Mayer/USDA Human Nutrition Research Center on Aging at Tufts University. Her major research interest is in flavonoids, population based nutrition surveys, and nutrition policy. Dr. Dwyer is the Director of the Frances Stern Nutrition Center at Tufts Medical Center and served as Dietetic Internship Director there from 1974 to 2009. From 2003-2011, and now as a contractor she Dr. Dwyer served as Senior Nutrition Scientist, Office of Dietary Supplements, National Institutes of Health. Dr. Dwyer received her D.Sc. and M.Sc. from the Harvard School of Public Health, an M.S. from the University of Wisconsin and the B.S. degree with distinction from Cornell University. She is the author or coauthor of more than 290 research articles and 360 review articles. She serves as the editor of Nutrition Today and co-editor of the Handbook of Nutrition and Food. She served on the 2000 Dietary Guidelines Advisory Committee. In 2015 she received the Excellence in Nutrition Education Award from the American Society for Nutrition, in 2014 she received the Trailblazer Award sponsored by the Institute of Food Technologies and the Academy of Nutrition and Dietetics, in 2013 she and the ODS team received a certificate of recognition from the National Institutes of Health, and in 2012 she was elected a fellow of the American Society for Parenteral and Enteral Nutrition. She served for 10 years as a member of the Food and Nutrition Board of the National Academy of Sciences, was elected member of the Institute of Medicine National Academy of Sciences in 1998, and served as Councilor of the Institute of Medicine from 2001-2003. Dr. Dwyer received an Honor Award from the Office of the Director, NIH in 2013, the Dean’s Medal from the Friedman School of Nutrition at Tufts in 2011, the Conrad V Elvejhem Award for public service in 2005 from the American Society for Nutrition Sciences, the Alumni Award of Merit from the Harvard School of Public Health in 2004, the WO Atwater award in 1996, the Medallion Award of the American Dietetic Association in 2003. She is a past president of the Society for Nutrition Education and the American Institute of Nutrition (now the American Society of Nutrition) and served as a Robert Wood Johnson Health Policy Fellow in the US Congress.
Eran Elinav, MD, PhD
Dr. Eran Elinav heads a research group at the Department of Immunology, Weizmann Institute of Science. His lab focuses on deciphering the molecular basis of host-microbiome interactions and their effects on health and disease, with a goal of personalizing medicine and nutrition. Dr. Elinav completed his medical doctor’s (MD) degree at the Hebrew University of Jerusalem Hadassah Medical Center summa cum laude, followed by a clinical internship, residency in internal medicine, and a clinical and research position at the Tel Aviv Medical Center Gastroenterology institute. He received a PhD in immunology from the Weizmann Institute of Science, followed by a postdoctoral fellowship at Yale University School of Medicine. Dr. Elinav has published more than 90 publications in leading pear-reviewed journals, including major recent discoveries related to the effects of host genetics, innate immune function and environmental factors, such as dietary composition and timing, on the intestinal microbiome and its propensity to drive multi-factorial disease. His honors include multiple awards for academic excellence including the Claire and Emmanuel G. Rosenblatt award from the American Physicians for Medicine (2011), the Alon Foundation award (2012), the Rappaport prize for biomedical research (2015), and the Lindner award (2016).
James C. Fleet, PhD
Dr. James Fleet is a Distinguished Professor in the Department of Nutrition Science as well as the Director of the Interdepartmental Nutrition Program for graduate training in nutrition at Purdue University. He holds a BS and PhD from Cornell University and has previously held faculty appointments at Tufts University and the University of North Carolina at Greensboro. Dr. Fleet's research is focused on the molecular and physiological functions of vitamin D as they pertain to the control of calcium metabolism and the prevention of cancer. He also conducts research on the interactions between genetics and diet influencing on bone health as well as the impact of nutrition on inflammation and immunity in the context of cancer. His research employs the tools of molecular biology, genomics, and genetics to address questions relevant to human health and disease prevention. He has published over 125 primary journal articles, book chapters and reviews and he has been an invited to speak on his work across the globe. His research has been supported by grants from the NIH, the USDA, and the American Institute for Cancer Research (AICR). He has served as a contributing editor to Nutrition Reviews, on the editorial boards of The Journal of Nutrition, and Endocrinology (current), and as a standing member on the INMP and CDP (current) study sections at NIH. He has organized FASEB Summer Conferences and a summer workshop on “Big Data analysis for Biomedical Researchers” and has served on the Program Committee for the Vitamin D Workshop (currently on the executive council), the American Society for Nutrition (ASN), the AICR, and the American Society for Bone and Mineral Research. In 2001, he was the recipient of the Mead Johnson Award from the ASN, in 2004 he was honored as a "University Faculty Scholar" by Purdue University, in 2012 he was awarded the designation of “distinguished professor” at Purdue (an honor awarded to just 5% of the Purdue faculty), and in 2014 he was inducted into the Purdue Department of Nutrition Science “Hall of Fame.”
Brian C. Focht, PhD, FACSM, CSCS
Dr. Brian Focht is the Director of the Exercise and Behavioral Medicine Lab in Kinesiology and an Associate Member of The Comprehensive Cancer Center and Food Innovation Center at The Ohio State University where his interdisciplinary research program examines the efficacy of lifestyle exercise physical and dietary interventions for health promotion and disease prevention among adults with or, at risk for, chronic disease. A primary focus of this line of inquiry is on exercise oncology, the implementation of exercise in the adjuvant treatment of cancer patients and survivors. Dr. Focht has served as the principal investigator and/or co-investigator of multiple, funded randomized controlled lifestyle intervention studies in knee osteoarthritis patients, prostate cancer patients, endometrial cancer survivors, and individual at risk for Type II diabetes. Specifically, he currently serves as the PI of the NIA funded Collaborative Lifestyle Intervention Program in Knee OA (CLIP-OA) Patients Trial. He has also served as the Principal Investigator of the recently completed NCI funded IDEA-P trial examining the efficacy of exercise and diet intervention in prostate cancer patients on androgen deprivation therapy as well as leading the IMPACT-P trial, a randomized controlled exercise pilot trial funded by the NIAMS targeting sedentary, knee osteoarthritis patients.
Dr. Focht’s research and professional interest is in the area of exercise and health psychology/behavior with a particular emphasis on exercise oncology, promotion of physical activity and dietary behavior change, and the effects of exercise/diet on quality of life. Dr. Focht has over 70 refereed publications and his research has been funded by the National Cancer Institute, National Institute of Arthritis, Musculoskeletal, and Skin Disorders, National Institute on Aging, the LIVESTRONG Foundation, and the OSU Comprehensive Cancer Center and Food Innovation Center. Dr. Focht is a Fellow of the American College of Sports Medicine, a National Strength and Conditioning Association Certified Strength and Conditioning Specialist, and has served as a consultant to the National Institutes of Health, Italian Ministry of Health, and Canadian Cancer Society.
Stephanie M. George, PhD, MPH, MA
Dr. Stephanie George is a Senior Epidemiologist at the National Institutes of Health Office of Disease Prevention in July 2015. In this role, she promotes the use of best available research methods, supports the development of better methods in prevention studies, and initiates and facilitates prevention research collaborations among the NIH, other federal agencies, and external stakeholders.
Before joining the ODP, Dr. George served as a postdoctoral fellow at the National Cancer Institute, where she led research to better understand the roles of diet quality, physical activity, and weight in the epidemiology of cancer and cancer survivorship. Her contributions also included methodological research to improve the assessment and analysis of those modifiable factors that contribute highly to disease burden in the United States.
Dr. George earned a PhD in Epidemiology and a Master of Public Health with a concentration in Chronic Disease Epidemiology from Yale University, and both a bachelor's and master's degree in Communication from the University of Maryland, College Park. She has received meritorious research awards from the National Institutes of Health, the Society of Behavioral Medicine, the Obesity Society, the Biennial Cancer Survivorship Conference, and the American Institute for Cancer Research.
Edward Giovannucci, MD, ScD
Dr. Edward Giovannucci graduated from Harvard University in 1980, and received a medical degree from the University of Pittsburgh School of Medicine in 1984. He did his residency in anatomic pathology at the University of Connecticut, and then returned to Boston, where he completed a doctoral degree in epidemiology from the Harvard School of Public Health in 1992.
Currently, he is a Professor in the Department of Medicine at the Harvard Medical School, and a Professor in the Departments of Nutrition and Epidemiology at the Harvard School of Public Health.
Over the past decade, much of Dr. Giovannucci’s work has been based in three large prospective studies: the Nurses’ Health Study and the Physicians’ Health Study based in Harvard Medical School, and the Health Professionals Follow-Up Study based in Harvard School of Public Health, Department of Nutrition.
His research focuses on how nutritional, environmental and lifestyle factors relate to various malignancies, especially those of the prostate and colorectum. A specific area of interest has been the etiologic mechanisms underlying the relation between these modifiable factors and cancer. In this regard, his work has included the study of how nutrition and other lifestyle factors impact on cancer risk by influencing levels of insulin, insulin-like growth factors, vitamin D metabolites, and steroid hormones. Another area of interest regards how nutrients may interact with genetic susceptibilities in determining an individual's risk. This work includes genetic variation in the vitamin D receptor, folate metabolizing enzymes, and the androgen receptor. Recent work on prostate cancer has focussed on the beneficial role of specific antioxidants, particularly lycopene and selenium, and on the potentially deleterious effects of diets high in calcium.
Heather Greenlee, ND, PhD
Dr. Heather Greenlee is Assistant Professor of Epidemiology at Columbia University’s Mailman School of Public Health. Dr. Greenlee trained in naturopathic medicine at Bastyr University and in epidemiology at the University of Washington and Columbia University. Her research focuses on the use of complementary and integrative medicine and lifestyle modifications for breast cancer prevention and control, with a specific interest in Latina breast cancer survivors. Dr. Greenlee uses observational studies and clinical trials to study what women can do, in addition to conventional treatment, to prevent breast cancer, decrease side effects of treatment, and improve prognosis. Dr. Greenlee has particular expertise in conducting behavioral trials related to dietary modification, increasing physical activity and weight management. Dr. Greenlee completed postdoctoral fellowships in cancer prevention and control at the Fred Hutchinson Cancer Research Center and Columbia University. Dr. Greenlee is an active member of SWOG within the National Cancer Institute’s National Cancer Clinical Trials Network and is Past President of the Society for Integrative Oncology (www.integrativeonc.org).
Peter Greenwald, MD, DrPH
Dr. Peter Greenwald is Associate Director for Prevention, Office of the Director, National Cancer Institute, NIH. In this position he assesses cancer prevention and early detection all across NCI. His major research interests include nutritional science, basic and pre-clinical chemoprevention studies through first-in-human to phase III clinical trials, biomarker discovery and validation, basic biometry and systems approaches to cancer prevention. In March 2011, he retired as director of the NCI Division of Cancer Prevention, which he established and led for 30 years, to take this new position. When he retired, he was Assistant Surgeon General (Rear Admiral) in the U.S. Public Health Service.
Dr. Greenwald graduated from Colgate University, received his medical degree from the State University of New York College of Medicine in Syracuse, and his Master degree and Doctorate in Public Health from the Harvard School of Public Health. He is Board-certified in both Internal Medicine and Preventive Medicine. Dr. Greenwald did a medical residency at Boston City Hospital, earned a doctoral degree in cancer epidemiology from Harvard, and was assistant in medicine at Peter Bent Brigham Hospital. After serving as director of epidemiology at the New York State Department of Health – with associated appointments at Albany Medical College and as Adjunct Professor of Biomedical Engineering at Rensselaer Polytechnic Institute – he joined the NCI in 1981 as a commissioned officer.
At the NCI, he built the Diet and Cancer Program, greatly increasing NCI grant support for scientists across the country. He provided leadership in research regarding the fundamental roles of dietary patterns and constituents in the etiology and prevention of cancer, the development of quantitative methods and markers for assessing dietary intake and nutritional status, human metabolic studies of nutrient and non-nutrient dietary constituents, and clinical trials of dietary modification for prevention. His NCI division led the “5 A Day” program in partnership with industry and the private sector to encourage Americans to eat more vegetables and fruits every day. Dr. Greenwald supported the development of many other prevention research and special population programs and is the author of about 300 book chapters and scientific papers.
Stephen D. Hursting, PhD, MPH
Dr. Stephen Hursting is Professor and Director of the Division of Nutritional Biochemistry in the Department of Nutrition at the University of North Carolina (UNC) at Chapel Hill. He is also Professor at the UNC Nutrition Research Institute and a member of the UNC Lineberger Comprehensive Cancer Center. He earned his PhD in nutritional biochemistry and MPH in nutritional epidemiology from UNC-Chapel Hill, and he completed postdoctoral training in molecular carcinogenesis and cancer prevention at the National Cancer Institute (NCI). Prior to joining the UNC faculty in 2014, Dr. Hursting was Professor and Chair of the Department of Nutritional Sciences at the University of Texas (UT) at Austin, the McKean-Love Endowed Chair of Nutritional, Molecular and Cellular Sciences in the UT College of Natural Sciences, and Professor of Molecular Carcinogenesis at the UT-MD Anderson Cancer Center (2005-14). He also previously served as Chief of the NCI’s Nutrition and Molecular Carcinogenesis Laboratory Section and Deputy Director of the NCI Cancer Prevention Fellowship Program (1999-2005). His research interests center on diet-gene interactions relevant to cancer prevention, particularly the molecular and metabolic mechanisms underlying obesity- cancer associations, and the interplay between obesity, metabolism and cancer. Primarily using preclinical models (including human and mouse cell lines and genetically engineered mouse models of cancer) in parallel with human studies, he is currently focusing on the molecular and metabolic changes occurring in response to lifestyle-based (dietary and physical activity), or pharmacologic manipulation of energy metabolism and cell signaling pathways, with emphasis on the insulin/IGF-1 signaling pathways as well as inflammation.
John M. Jakicic, PhD
Dr. John Jakicic is a Professor in the Department of Health and Physical Activity, and is also the Director of the Physical Activity and Weight Management Research Center at the University of Pittsburgh. Dr. Jakicic has also been on the faculty at Brown University, the University of Kansas, and the University of Nebraska-Kearney. Dr. Jakicic has a national and international reputation as a leading scholar in this area of physical activity and weight control, and this builds on a line of research to determine the appropriate dose of physical activity for long-term body weight regulation. Within this line of research Dr. Jakicic studies the interaction between energy expenditure and energy intake, and the influence of these factors on body weight regulation. Specifically, Dr. Jakicic’s early research was key to the public health recommendation that physical activity can be beneficial when separated into multiple 10-minute sessions per day. Dr. Jakicic is also an expert in the implementation of strategies to improve long-term adherence to physical activity, and the understanding of behavioral and physiological mechanisms that are involved with linking physical activity to body weight regulation. He has also been at the forefront of applying technology to physical activity interventions, which includes wearable technologies and low-intensity intervention strategies for lifestyle behavior change. Dr. Jakicic has served on various national and international committees to develop physical activity guidelines for the prevention and treatment of obesity and other chronic conditions. Thus, he has been influential in the heightened awareness of physical activity as a key lifestyle behavior to improve health.
Susan M. Krebs-Smith, PhD
Dr. Susan Krebs-Smith is Chief of the Risk Factor Assessment Branch, in the Division of Cancer Control and Population Sciences, at the U.S. National Cancer Institute. In that capacity, she oversees a program of research on the surveillance of risk factors related to cancer including diet, physical activity, and weight status; methodological issues to improve the assessment of those factors; and issues related to guidance and food policy. Her own surveillance research has emphasized trends in intake of foods and nutrients, especially fruits and vegetables and added sugars; food sources of nutrients; and factors associated with the intake of foods and/or nutrients, using data from the National Health and Nutrition Examination Survey. Her contributions in the area of dietary assessment methodology have focused on developing methods to assess dietary patterns, the usual intake of foods, overall diet quality and conformance to dietary guidelines. Her efforts in dietary guidance and food policy include evaluation of the US food supply and estimating future demand for food commodities, based on population-wide adoption of the Dietary Guidelines and census projections.
Dr. Krebs-Smith has been a member of several National Academies’ Committees, and has served on the editorial boards for the British Journal of Nutrition, the Journal of the Academy of Nutrition and Dietetics, and the Journal of Nutrition Education and Behavior and on the Governing Council of the American Public Health Association.
Dr. Krebs-Smith received a Bachelor’s degree in Home Economics from Bradley University, a Master of Public Health degree from the University of Minnesota, and a Doctorate in Nutrition from The Pennsylvania State University.
Johanna Lampe, PhD, RD
Dr. Johanna Lampe is a Full Member and Associate Division Director in the Public Health Sciences Division at Fred Hutchinson Cancer Research Center and a Research Professor in the Department of Epidemiology at the University of Washington in Seattle. Currently, she also serves as Interim Program Head of the Cancer Prevention Program at the Hutch. She received her PhD in nutritional sciences, with a minor in biochemistry, from the University of Minnesota and trained as a post-doctoral fellow in epidemiology at the University of Minnesota before joining the faculty at Fred Hutchinson Cancer Research Center in 1994. Dr. Lampe has had a long standing research program on the effect of diet constituents on biomarkers of cancer susceptibility in humans and the effects of genetic variation on response to diet. Her lab also studies the modifying effects of the gut microbiome on phytochemical metabolism and collaborates on several NIH-funded studies of the gut microbiome and health. Dr. Lampe is a member of the American Association for Cancer Research (AACR), the American Society for Nutrition (ASN), the Academy of Nutrition and Dietetics (AND), and the European Groupe Polyphénols. In 2014, Dr. Lampe received the ASN Mary Swartz Rose Senior Investigator Award for research on the safety and efficacy of bioactive compounds for human health.
Vanessa A. Leone, PhD
Dr. Vanessa Leone is currently an Instructor in the Department of Medicine, Section of Gastroenterology, Hepatology, and Nutrition at the University of Chicago. She obtained her PhD in Animal Science and Nutrition at the University of Wisconsin – Madison. Here, her work focused on the effects of maternal dietary supplementation on embryogenesis using an avian model. In her postdoctoral studies at the University of Chicago, Dr. Leone shifted the focus of her work to examine the influence of the gut microbiome on complex disease development. Studies have shown that lifestyle changes, particularly Western, high fat high carbohydrate diet-induced gut microbiota play a role in the development of metabolic disturbances, including obesity and Type II diabetes. Dr. Leone’s recent work suggests that gut microbes exhibit day versus night (or diurnal) oscillatory patterns, which are crucial to maintain the host circadian system. Coordination between our ‘gut microbial clock’ and our own circadian clock aids in synchronizing host metabolic function. The goal of her current studies is to determine how the diurnal patterns of diet-induced gut microbiota influence the host circadian system in the context of diet-induced obesity. In performing these studies, Dr. Leone hopes to mechanistically define what makes up a microbial oscillator versus a non-oscillator, examine how specific host factors impact the broader diurnal structure and functional capacity of the gut microbiome, and what the underlying implications of microbial oscillations are for host physiological homeostasis. Together, the long-term goal of Dr. Leone’s research is to determine how oscillations of gut microbes influence diurnal dynamics of intestinal host factors that aid in maintenance of a host-microbe symbiotic relationship. This knowledge could lead to development of new strategies to prevent and treat diet-induced obesity.
Gregory B. Lesinski, PhD, MPH
Dr. Gregory Lesinski is an Associate Professor in The Department of Internal Medicine, Division of Medical Oncology at The Ohio State University. Dr. Lesinski received his PhD (Biomedical Sciences) in 2001 from The Medical College of Ohio in Toledo and trained as a post-doctoral fellow under the direction of Dr. William E. Carson, III in cancer immunology at The Ohio State University from 2001 – 2005. He joined the OSU faculty in 2005 as a Research Assistant Professor in the Department of Molecular Virology, Immunology and Medical Genetics. In 2008, Dr. Lesinski was recruited to the Division of Medical Oncology as a Tenure-Track Assistant Professor. As part of an NIH training grant Dr. Lesinski also received a master’s degree in public health (MPH) in 2012. He was later promoted to an Associate Professor, with Tenure in 2014. Dr. Lesinski’s research is focused on gaining a greater understanding of the interactions between the host immune system and tumor cells. The ultimate goal is to use this knowledge to develop novel therapeutic and chemopreventive approaches to help patients with cancer, and improve upon existing therapies. Most recently, Dr. Lesinski has integrated his research laboratory with the efforts of the Division of Gastroenterology, Hepatology and Nutrition (GHN) and has been appointed as the Director of the GHN Division Laboratory. Here his research team pursues studies on how inflammation regulates interactions between the immune system and cancer. His laboratory is currently the site for correlative studies associated with several solid tumor oncology clinical trials, and a biobank for samples from patients with gastrointestinal cancer and inflammatory disorders. Dr. Lesinski has authored more than 65 publications or book chapters in the area of basic science and translational research on solid tumor oncology, immunotherapy and clinical trials. Dr. Lesinski has maintained continuous funding from The National Institutes of Health for his work since 2008, including K22, R21 and R01 grants focused on cancer immunology, dietary soy, pancreatitis, and development of small molecule inhibitors of the oncogenic STAT3 transcription factor. He has also received a number of foundation grants for his research on melanoma, immunotherapy, and pancreatic disease. He regularly reviews ad hoc for NIH and other study sections and is a permanent member of the NCI Chemo/Dietary Prevention (CDP) review panel. Dr. Lesinski holds professional memberships through The American Association for Cancer Research, The Society for Immunotherapy of Cancer, The American Association for Immunologists and The Society for Melanoma Research and has numerous active collaborations with clinical and basic science investigators focused on modulating immune function for cancer therapy and prevention.
Sarah Lewis, PhD
Dr. Sarah Lewis obtained a BSc in Genetics at the University of Sheffield in 1995 and then went on to complete a PhD in Genetic Epidemiology at the University of Manchester in 1999. She then had a series of short postdoctoral positions including a post at the International Agency for Research on Cancer. Dr. Lewis joined the School of Social and Community Medicine in January 2004 as a lecturer in Genetic Epidemiology and was promoted to Senior Lecturer in 2009. Her research interests are in using Mendelian Randomization to understand risk factors for cancer and to identify modifiable factors which influence in utero development. Dr. Lewis has over 80 peer review publications many of which are in the field of cancer. She has recently been involved in a study which shows that a younger age of puberty in men is a risk factor for prostate cancer, and another study which shows that the IGF pathway is likely to be a causal factor in prostate cancer. From 2013, Dr. Lewis has managed a working group to develop a framework for carrying out systematic reviews of mechanistic studies of exposures and cancer, a project which has been funded by the World Cancer Research Fund UK.
Angela D. Liese, PhD, MPH, FAHA
Dr. Angela Liese is a Professor of Epidemiology at the University of South Carolina’s (UofSC) Arnold School of Public Health where she teaches advanced methods in epidemiology. Dr. Liese is an active member of the American College of Epidemiology and a fellow of the American Heart Association (AHA) and is trained in both nutrition and epidemiology. Dr. Liese conducts research in the area of nutrition, food security, diabetes and cardiovascular disease, and has received funding from the National Institutes of Health, the Centers for Disease Control and Prevention, the American Diabetes Association, the AHA, and the United States Department of Agriculture. Dr. Liese has authored more than 140 peer-reviewed publications. Her research on dietary pattern methods and the association of diet patterns with health outcomes and mortality has affected nutritional epidemiology methods and public health nutrition recommendations. Dr. Liese also served as the director of UofSC’s Center for Research in Nutrition and Health Disparities (2008-13), for which she created a network of some 50 interdisciplinary faculty and staff working on collaborative and individual research projects. Together with colleagues at the National Cancer Institute, Dr. Liese initiated the Dietary Patterns Methods project, an inter-institutional research collaboration. In her 16 years at UofSC she not only mentored undergraduate and graduate students, but dozens of junior faculty. In 2016, Dr. Liese was recognized for her mentorship in research with the university’s Breakthrough Leadership in Research Award.
Anne McTiernan, MD, PhD
Dr. Anne McTiernan is a Full Member at the Fred Hutchinson Cancer Research Center and Research Professor at the University of Washington Schools of Medicine and Public Health. Her research focuses on diet, obesity, exercise, and risk for cancer development and prognosis. She was Principal Investigator of the NCI-funded Seattle Transdisciplinary Research on Energetics and Cancer program that investigated mechanisms linking obesity and sedentary lifestyles with cancer. She has received research funding from the NIH, the Breast Cancer Research Foundation, and Susan G. Komen. She is an elected Fellow in the American College of Sports Medicine and the Obesity Society. She has published more than 390 scientific manuscripts, is lead author of the book, Breast Fitness (St. Martin’s Press, 2000), and Editor of Cancer Prevention and Management through Exercise and Weight Control (CRC Press LLL, 2005) and Physical Activity, Dietary Calorie Restriction, and Cancer (Springer; 2010). Her committee service related to nutrition includes the WCRF/AICR expert panel, the 2008 U.S. Physical Activity Guidelines Advisory Committee, the International Agency for Research on Cancer, and the American Cancer Society. Dr. McTiernan’s memoir Starved: A Nutrition Doctor’s Journey from Empty to Full (Central Recovery Press) will be published in November, 2016.
Steven C. Moore, PhD, MPH
Dr. Steven Moore received his PhD in Cancer Epidemiology from Yale University School of Public Health and joined the Nutritional Epidemiology Branch in the Division of Cancer Epidemiology and Genetics of NCI as a Pre-doctoral Fellow in 2005 and he later became a Research Fellow in 2009. In 2013, he was selected as part of the Earl Stadtman Investigator Search and he is now a tenure-track investigator in the Metabolic Epidemiology Branch of NCI.
Dr. Moore’s research focuses on the role of physical activity and obesity in relation to cancer risk. He has explored these questions in large pooled analyses of 12 cohorts and 1.4 million participants in the NCI Cohort Consortium. His latest study reported that physical activity was inversely associated with risk of 13 different cancers within the NCI Cohort Consortium. In the past several years, Dr. Moore has also helped lay crucial groundwork for incorporating metabolomics—a high-throughput method used to measure 100s or 1000s of metabolites in biospecimens like blood or urine—into epidemiologic studies. His studies of the metabolomics of energy balance have been instrumental in uncovering biomarkers for body mass index and diet, some of which may be relevant to cancer etiology. Dr. Moore is currently leading studies to identify metabolites and metabolic pathways involved in breast and kidney cancers. Dr. Moore currently serves as the chair of COMETS, a consortium of 23 prospective cohorts that are using metabolomics to better understand disease etiology.
Marian L. Neuhouser, PhD, RD
Dr. Marian Neuhouser is a Full Member in the Cancer Prevention Program, Division of Public Health Sciences at the Fred Hutchinson Cancer Research Center in Seattle, Washington as well as Core Faculty in Nutritional Sciences and Affiliate Professor of Epidemiology at the University of Washington. Her research focus for the past 20 years has been the role of nutrition in the prevention and survivorship of breast and prostate cancers and other diet-related chronic diseases. She is Principal Investigator or Co-Investigator of multiple NIH-funded grants ranging from controlled feeding trials to large population-based cohorts, including some based on special populations such as minorities and the elderly. Dr. Neuhouser also leads the Fred Hutch’s Nutrition Assessment Shared Resource and spends a focused portion of her research on improving dietary assessment methods. Dr. Neuhouser has authored over 250 peer-reviewed publications and a dozen book chapters related to dietary assessment methods, diet and health and cancer prevention. Dr. Neuhouser is a member of the American Association for Cancer Research, the Academy of Nutrition and Dietetics, the American Society for Preventive Oncology and the American Society for Nutrition. She is currently President of the American Society for Nutrition. Dr. Neuhouser served as a member of the 2015 Dietary Guidelines Advisory Committee.
Mary Platek, PhD, RD
Dr. Mary Platek is an epidemiologist and a Registered Dietitian. She has worked in the area of nutrition screening, assessment and intervention in the setting of oncology. She focuses on head and neck cancer patients, a population that is high risk for malnutrition. Her research centers on the prevention and management of cancer-related malnutrition and cachexia with a concentration on supportive nutrition care to minimize treatment toxicity and improve quality of life throughout survivorship. She is an advocate for the inclusion of validated malnutrition screening as standard of care for all oncology outpatients and promotes the application of evidence based nutrition intervention protocols in the nutritional care of the oncology outpatient. She has authored peer-reviewed articles on these topics, and has spent a significant portion of her professional career dedicated to the teaching and training of nutrition students and dietetic trainees. Dr. Platek received her education and training through the State University of New York at Buffalo. She completed an NIH Fellowship in the Epidemiologic and Basic Science of Cancer Prevention and Control at Roswell Park Cancer Institute (RPCI). Before returning to RPCI she was an Assistant Professor of Clinical Nutrition at New York University and is currently an Assistant Professor of Oncology at RPCI.
Jill Reedy, PhD, MPH, RD
Dr. Jill Reedy is a Program Director and Nutritionist in the Risk Factor Assessment Branch of the Epidemiology and Genomics Research Program within the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI).
Dr. Reedy leads the Dietary Patterns Methods Project, a collaborative effort to move forward dietary patterns research. She has also worked with colleagues at NCI and USDA to update the Healthy Eating Index and has compared it with other diet quality indices, tested its predictive validity, and applied it as a measure of the food environment.
Dr. Reedy is a member of the National Collaborative on Childhood Obesity Research (NCCOR) and worked with colleagues to develop the Measures Registry (available at www.nccor.org/measures). She served as a member of the Technical Expert Collaborative for USDA’s Dietary Patterns Systematic Review Project and was part of the Data Analysis Team for the 2015 Dietary Guidelines Advisory Committee.
Cheryl Rock, PhD, RD
Dr. Cheryl Rock is a Professor in the Department of Family Medicine and Public Health, and the Cancer Prevention and Control Program, University of California, San Diego, School of Medicine. She completed undergraduate training in nutrition and dietetics at Michigan State University, achieved a Master of Medical Science degree in clinical nutrition at Emory University, and was awarded a doctoral degree in nutritional sciences from the University of California, Los Angeles. Dr. Rock’s research efforts are focused on the role of nutritional and dietary factors in the development and progression of cancer, particularly breast cancer, and healthy weight management in adults. Her research efforts address diet composition and weight management, and how diet, adiposity and physical activity affect biomarkers and disease risk and progression.
Dr. Rock has been involved in several large trials funded by the National Institutes of Health (NIH) and the American Cancer Society, testing whether healthy weight control and modifications in diet and physical activity can alter biological processes, hormonal factors, body weight, progression of cancer, and cardiovascular disease risk factors. Dr. Rock leads a clinical trial project and the biorepository core for the NIH-funded Transdisciplinary Research in Energetics and Cancer Center (TREC) at UCSD. She also currently serves as PI of a clinical trial testing the effects of diet composition on weight loss, cardiovascular disease and cancer biomarkers, and meal satiety funded by the American Institute for Cancer Research and the California Walnut Commission. Additionally, she is a co-investigator on NIH-funded studies that are focused on obesity, various weight loss interventions and strategies, and the behavioral and metabolic factors associated with disease risk. Dr. Rock leads the Diet and Physical Activity Shared Resource of the Moores UCSD Comprehensive Cancer Center, a multifaceted laboratory, dietary and physical activity assessment, and behavioral counseling recharge service unit.
Dr. Rock has served on numerous NIH and USDA review panels and committees, and she has served on editorial boards for several peer-reviewed journals. To date, Dr Rock is the author of more than 240 scientific papers and book chapters.
Barbara J. Rolls, PhD
Dr. Barbara Rolls received her PhD in Physiology from the University of Cambridge, England. After spending her early research career at the University of Oxford, Dr. Rolls became Professor of Psychiatry at Johns Hopkins University School of Medicine. In 1992, she joined The Pennsylvania State University faculty, where she is Professor and the Helen A. Guthrie Chair of Nutritional Sciences.
Dr. Rolls’ research focuses on satiety and obesity. Her studies that received a MERIT award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) have demonstrated how characteristics of foods such as variety, energy density, and portion size can influence energy intake across the lifespan.
She has published more than 250 research articles and six books including Thirst and The Ultimate Volumetrics Diet. Dr. Rolls’ Volumetrics Diet, which is based on eating low calorie dense foods such as fruits and vegetables to feel full while eating fewer calories, has been ranked among U.S. News & World Report’s top 10 diets since 2011.
Dr. Rolls has served as President of both the Society for the Study of Ingestive Behavior and The Obesity Society, and has served on the Advisory Council of NIDDK.
Her awards and honors include Academy of Nutrition and Dietetics Honorary Member, American Association for the Advancement of Science Fellow, International Award for Modern Nutrition, Atwater Lecturer, American Society for Nutrition (ASN) Award in Human Nutrition, The Obesity Society’s Bray Founders Award, ASN Fellow, ASN David Kritchevsky Career Achievement Award, and the Society for the Study of Ingestive Behavior Hoebel Award for Creativity.
Michael Rosenbaum, MD
Dr. Michael Rosenbaum received his undergraduate degree from Amherst College and his medical degree from Cornell University Medical College. After completing his internship and residency at Columbia Presbyterian (Babies) Hospital and a fellowship in Pediatric Endocrinology at The New York Hospital he joined the Laboratory of Human Behavior and Metabolism under the direction of Dr. Jules Hirsch at Rockefeller University. In 1997 he came to Columbia with Dr. Rudolph Leibel. He is currently a Professor of Clinical Pediatrics and Medicine at CUMC where is also the Associate Program Director of the Clinical Research Resource within the Clinical Translational Science Award (CTSA).
Dr. Rosenbaum’s research interests mostly focus on the pathophysiology and molecular physiology of body weight regulation in adults and the development and prevention of obesity and its co-morbidities in children. Current projects examine the effects of dietary macronutrient content on biochemistry, behavior, and energy intake and output in adults and the effects of an at-risk SNP of the FTO gene on energy intake in children. He has received an ECRIP Center grant from New York State and will be directing a multispecialty program for research and treatment of pediatric obesity that will open in August of 2016. He hopes that this program will be a valuable resource to multiple divisions interested in the development of degenerative diseases across the lifespan.
Dr. Rosenbaum has received a number of awards and has authored over 100 peer-reviewed publications. Along with his colleague Dr. Rudolph Leibel, he is internationally known for this work. He has served as a mentor on numerous internal and external grants for young investigators, NIH study sections and sub-committees, and is an active part of the teaching faculty at Columbia. He is a member of the American Academy of Pediatrics, the American Diabetes Association, the Obesity Society, and the Society for Pediatric Research and he was one of 20 Columbia University faculty members chosen as inaugural fellows in the Columbia Public Voices Fellowship program, a collaboration of Columbia’s Department of Medicine and the OpEd Project to cultivate national thought leaders among scholars, scientists, and clinicians who can influence the larger public debate beyond the walls of academia. His work is currently funded by the NIH, the New York State Empire Clinical Research Investigator Program, and the Nutrition Science Initiative.
Cornelia Ulrich, PhD
Dr. Cornelia Ulrich is a cancer epidemiologist whose research focuses on lifestyle and biologic factors in cancer prevention and cancer prognosis. She is Senior Director of Population Sciences at Huntsman Cancer Institute (HCI) and Professor and Division Chief of Cancer Population Sciences in the Department of Population Health Sciences at the University of Utah. She came to HCI from the German Cancer Research Center and National Center for Tumor Diseases, where she was Director, as well as Head of the Department of Preventive Oncology. She also continues to collaborate with the Fred Hutchinson Cancer Research Center, her former research institution. Dr. Ulrich leads an interdisciplinary team of scientists on research related to the prevention, epidemiology, prognosis, and survivorship of cancer. Major research areas include personalized cancer prevention with aspirin or other anti-inflammatory drugs; nutrition; connections between obesity, adipose tissue, and the progression of cancer; and the role of energy balance and physical activity in cancer prevention and cancer survivorship. Dr. Ulrich is also Principal Investigator of the HCI in the ORIEN network of cancer centers.
Dr. Ulrich has published more than 280 publications, including the book “Exercise, Energy Balance, and Cancer (Springer, 2012). She is an elected member to the European Academy of Cancer Sciences, and serves on numerous national and international advisory boards, committees, and editorial boards, including several of the National Institutes of Health, International Agency for Research on Cancer and American Association of Cancer Research.
Krista Varady, PhD
Dr. Krista Varady is an Associate Professor of Nutrition at the University of Illinois, Chicago. Her research focuses on the efficacy of alternate day fasting for weight loss, weight maintenance, and cardio-protection in obese adults. Her work is funded by the NIH, American Heart Association, International Life Sciences Institute, and the University of Illinois. She has published over 50 publications on this topic, and is also the author of a book for the general public, entitled the "Every Other Day Diet".
Corrie M. Whisner, PhD
Dr. Corrie Whisner is an Assistant Professor of Nutrition in the School of Nutrition and Health Promotion at Arizona State University (ASU). After receiving both her BS and PhD in Nutrition Science from Purdue University, she was a USDA Agriculture and Food Research Initiative postdoctoral fellow in the Division of Nutritional Sciences at Cornell University. Dr. Whisner’s research at ASU builds on both her doctoral and postdoctoral experiences which focused on nutrient metabolism in pediatric populations. During her doctoral work she studied the effects of prebiotic (novel dietary fiber) supplementation on calcium absorption and the gut microbiome in healthy adolescent boys and girls. Dr. Whisner utilized her postdoctoral training to expand her research expertise to include the effects of maternal diet on prenatal bone loss and fetal programming among pregnant adolescents. Currently, Dr. Whisner’s research focuses on the intricate relationships between dietary intake and intestinal microbial communities. Her work includes observational studies aimed at identifying dietary factors that impact the intestinal microbiome and supplementation trials to alter systemic metabolic health via microbial functions. Specific areas of systemic health that she has expertise in include osteoporosis and obesity. Most recently, Dr. Whisner has completed a longitudinal study of college freshmen to assess how changes in lifestyle behaviors (diet, exercise and stress) impact the intestinal microbiome and subsequent weight-related outcomes.
Dr. Whisner is a member of the American Society for Nutrition (ASN) and is currently serving a two-year campaign on the Public Information Committee. She has also provided regular blog entries on the ASN blog and was a student representative for the Vitamins and Minerals Research Interest Section as a postdoc. In her short tenure at ASU, she has become a faculty affiliate with the Southwest Interdisciplinary Research Center, a national Exploratory Center of Excellence on minority health and health disparities, as well as a Core Faculty Member of the Fundamental and Applied Microbiomics Research Center. In June 2015, Dr. Whisner was one of 20 early career professional inductees into the Dannon Institute’s Nutrition Leadership Institute and a recipient of a “Diamond of the Department” award from her alma mater in May 2016.
Walter C. Willett, MD, DrPH
Dr. Walter Willett is Professor of Epidemiology and Nutrition and Chairman of the Department of Nutrition at Harvard School of Public Health and Professor of Medicine at Harvard Medical School. Dr. Willett, an American, was born in Hart, Michigan and grew up in Madison, Wisconsin, studied food science at Michigan State University, and graduated from the University of Michigan Medical School before obtaining a Doctorate in Public Health from Harvard School of Public Health. Dr. Willett has focused much of his work over the last 35 years on the development of methods, using both questionnaire and biochemical approaches, to study the effects of diet on the occurrence of major diseases. He has applied these methods starting in 1980 in the Nurses’ Health Studies I and II and the Health Professionals Follow-up Study. Together, these cohorts that include nearly 300,000 men and women with repeated dietary assessments are providing the most detailed information on the long-term health consequences of food choices.
Dr. Willett has published over 1,600 articles, primarily on lifestyle risk factors for heart disease and cancer, and has written the textbook, Nutritional Epidemiology, published by Oxford University Press. He also has four books for the general public, Eat, Drink and Be Healthy: The Harvard Medical School Guide to Healthy Eating, which has appeared on most major bestseller lists, Eat, Drink, and Weigh Less, co-authored with Mollie Katzen, The Fertility Diet, co-authored with Jorge Chavarro and Pat Skerrett and Thinfluence co-authored with Malissa Wood and Dan Childs. Dr. Willett is the most cited nutritionist internationally, and is among the five most cited persons in all fields of clinical science. He is a member of the Institute of Medicine of the National Academy of Sciences and the recipient of many national and international awards for his research.